Chemokine-Based Therapeutics for the Treatment of Inflammatory and Fibrotic Convergent Pathways in COVID-19
Dana R. Julian, Megan A. Kazakoff, Akhil Patel, Jesse M. Jaynes, Monte S. Willis, Cecelia C. Yates
Topics & Concepts
MedicineFibrosisImmunologyCXCL10ChemokineCytokine stormARDSPulmonary fibrosisCXCR3InflammationLungPathologyDiseaseCoronavirus disease 2019 (COVID-19)Infectious disease (medical specialty)Internal medicineChemokine receptorCOVID-19 Clinical Research StudiesLong-Term Effects of COVID-19SARS-CoV-2 and COVID-19 Research